Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Melatonin for Prevention of Kidney Injury — Stella

Home/Acute Kidney Injury/Melatonin for Prevention of Kidney Injury

View on ClinicalTrials.gov

Recruiting

Back to Acute Kidney Injury trials

Melatonin for Prevention of Kidney Injury

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

United States

Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey

Key details

Phase

Large-scale testing

Sponsor

Rutgers, The State University of New Jersey

Enrollment target

~300 participants

Started

June 2023

Primary completion

June 2027

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.